| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |